Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 2/20 | 0.55 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.55 |
| ▸ | RELA | Q04206 | 2/20 | 0.55 |
| ▸ | NR1H2 | P55055 | 4/20 | 0.39 |
| ▸ | NR1H3 | Q13133 | 4/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13698111 | 1.00 | NFKB1 (0.55) | NFKB1NFKB2RELANR1H2NR1H3 | |
| SCHEMBL13698112 | 1.00 | NFKB1 (0.55) | NFKB1NFKB2RELANR1H2NR1H3 | |
| SCHEMBL13895145 | 0.89 | NFKB1 (0.54) | NFKB1NFKB2RELANR1H2NR1H3 | |
| SCHEMBL13895010 | 0.89 | NFKB1 (0.54) | NFKB1NFKB2RELANR1H2NR1H3 | |
| Aceroside B1 SCHEMBL13698046 | 0.87 | NFKB1 (0.49) | NFKB1NFKB2RELAACHE | |
| Aceroside I SCHEMBL15996716 | 0.87 | NFKB1 (0.49) | NFKB1NFKB2RELAACHE | |
| Aceroside B1 SCHEMBL4101421 | 0.87 | NFKB1 (0.49) | NFKB1NFKB2RELAACHE | |
| Aceroside B1 SCHEMBL15996711 | 0.87 | NFKB1 (0.49) | NFKB1NFKB2RELAACHE | |
| Aceroside I SCHEMBL13698044 | 0.87 | NFKB1 (0.49) | NFKB1NFKB2RELAACHE | |
| Aceroside I SCHEMBL15996710 | 0.87 | NFKB1 (0.49) | NFKB1NFKB2RELAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2407160-A1 | Pharmaceutical composition for prevention and/or treatment of bone disease, functional food or health food comprising the composition, and pharmaceutical preparation comprising the composition as active ingredient | Akihisa, Toshihiro (JP) | 2012-01-18 | — | — | EP | disclosed |